Anne Secor

Concept 3: INVESTIGATIONAL PILL TREATMENT There’s a pill for this? NASH Clinical Trial for NASH Now Enrolling ( N O N A L C O H O L I C S T E AT O H E P AT I T I S ) Large Mobile Banner (320×100) NASH There’s a pill for this? ( N O N A L C O H O L I C S T E AT O H E P AT I T I S ) NASH There’s a pill for this? ( N O N A L C O H O L I C S T E AT O H E P AT I T I S ) Clinical Trial for NASH Now Enrolling Medium Rectangle (300×250) There’s a pill for this? NASH ( N O N A L C O H O L I C S T E AT O H E P AT I T I S ) Clinical Trial for NASH Now Enrolling Half Page (300×600) Clinical Trial for NASH Now Enrolling Large Rectangle (336×280) There’s a pill for this? Clinical Trial for NASH Now Enrolling Large Mobile Banner (728×90) NASH ( N O N A L C O H O L I C S T E AT O H E P AT I T I S ) Concept 2: ALL TYPE THESE RISK FACTORS MAY LEAD TO NASH 1 (NONALCOHOLIC STEATOHEPATITIS) 1 OVERWEIGHT • DIABETES • HIGH BLOOD PRESSURE • FATTY LIVER YOU MAY QUALIFY FOR A NASH CLINICAL TRIAL LEARN MORE 1) Source: Lonardo A, Nascimbeni F, Mantovani A, Targher G. “Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?” J Hepatol Large Mobile Banner (320×100) THESE RISK FACTORS MAY LEAD TO NASH1: OVERWEIGHT • DIABETES • HIGH BLOOD PRESSURE • FATTY LIVER YOU MAY QUALIFY FOR A NASH (NONALCOHOLIC STEATOHEPATITIS) 1 CLINICAL TRIAL LEARN MORE THESE RISK FACTORS MAY LEAD TO NASH1 (NONALCOHOLIC STEATOHEPATITIS)1 OVERWEIGHT DIABETES HIGH BLOOD PRESSURE FATTY LIVER YOU MAY QUALIFY FOR A NASH CLINICAL TRIAL LEARN MORE 1) Source: Lonardo A, Nascimbeni F, Mantovani A, Targher G. “Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?” J Hepatol Medium Rectangle (300×250) THESE RISK FACTORS MAY LEAD TO NASH1 (NONALCOHOLIC STEATOHEPATITIS)1 OVERWEIGHT DIABETES HIGH BLOOD PRESSURE FATTY LIVER YOU MAY QUALIFY FOR A NASH CLINICAL TRIAL LEARN MORE 1) Source: Lonardo A, Nascimbeni F, Mantovani A, Targher G. “Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?” J Hepatol Half Page (300×600) 1) Source: Lonardo A, Nascimbeni F, Mantovani A, Targher G. “Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?” J Hepatol Large Rectangle (336×280) T H E S E R I S K F A C T O R S M AY L E A D T O N A S H ( N O N A L C O H O L I C S T E AT O H E PAT I T I S ) 1 O V E R W E I G H T • D I A B E T E S • H I G H B L O O D P R E S S U R E • F AT T Y L I V E R YOU MAY QUALIFY FOR A NASH CLINICAL TRIAL 1) Source: Lonardo A, Nascimbeni F, Mantovani A, Targher G. “Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?” J Hepatol Large Mobile Banner (728×90) LEARN MORE